214 related articles for article (PubMed ID: 31955822)
1. Recent advances of long noncoding RNAs involved in the development of multiple sclerosis.
Li QW; Lei W; Chen C; Guo W
Chin J Nat Med; 2020 Jan; 18(1):36-46. PubMed ID: 31955822
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of OIP5-AS1/HUR1 to discover new potential biomarkers and therapeutic targets in multiple sclerosis.
Gharesouran J; Taheri M; Sayad A; Mazdeh M; Omrani MD
J Cell Physiol; 2019 Aug; 234(10):17351-17360. PubMed ID: 30815864
[TBL] [Abstract][Full Text] [Related]
3. HOTAIR but not ANRIL long non-coding RNA contributes to the pathogenesis of multiple sclerosis.
Pahlevan Kakhki M; Nikravesh A; Shirvani Farsani Z; Sahraian MA; Behmanesh M
Immunology; 2018 Apr; 153(4):479-487. PubMed ID: 29030863
[TBL] [Abstract][Full Text] [Related]
4. Noncoding RNAs in multiple sclerosis.
Yang X; Wu Y; Zhang B; Ni B
Clin Epigenetics; 2018 Nov; 10(1):149. PubMed ID: 30497529
[TBL] [Abstract][Full Text] [Related]
5. Role of long non-coding RNAs (LncRNAs) in multiple sclerosis: a brief review.
Taghizadeh E; Taheri F; Samadian MM; Soudyab M; Abi A; Gheibi Hayat SM
Neurol Sci; 2020 Sep; 41(9):2443-2451. PubMed ID: 32350675
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNAs in autoimmune diseases.
Xu F; Jin L; Jin Y; Nie Z; Zheng H
J Biomed Mater Res A; 2019 Feb; 107(2):468-475. PubMed ID: 30478988
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNAs, Novel Offenders or Guardians in Multiple Sclerosis: A Scoping Review.
Jalaiei A; Asadi MR; Sabaie H; Dehghani H; Gharesouran J; Hussen BM; Taheri M; Ghafouri-Fard S; Rezazadeh M
Front Immunol; 2021; 12():774002. PubMed ID: 34950142
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients.
Santoro M; Nociti V; Lucchini M; Loiodice M; Centofanti F; Botta A; Losavio FA; De Fino C; Mirabella M
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3267-3273. PubMed ID: 32271444
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis.
Wang W; Yang N; Wen R; Liu CF; Zhang TN
Front Cell Infect Microbiol; 2021; 11():563126. PubMed ID: 34055659
[TBL] [Abstract][Full Text] [Related]
10. LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients.
Fenoglio C; Oldoni E; Serpente M; De Riz MA; Arcaro M; D'Anca M; Pietroboni AM; Calvi A; Lecchi E; Goris A; Mallants K; Dubois B; Comi C; Cantello R; Scarpini E; Galimberti D
J Neuroimmunol; 2018 Nov; 324():129-135. PubMed ID: 30170791
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNAs and Cardiac Disease.
Greco S; Salgado Somoza A; Devaux Y; Martelli F
Antioxid Redox Signal; 2018 Sep; 29(9):880-901. PubMed ID: 28699361
[TBL] [Abstract][Full Text] [Related]
13. The role of non-coding RNAs in neuroinflammatory process in multiple sclerosis.
Nowak A; Wicik Z; Wolska M; Shahzadi A; Szwed P; Jarosz-Popek J; Palatini J; Postula M; Czlonkowska A; Mirowska-Guzel D; Eyileten C
Mol Neurobiol; 2022 Aug; 59(8):4651-4668. PubMed ID: 35589919
[TBL] [Abstract][Full Text] [Related]
14. Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.
Cardamone G; Paraboschi EM; Soldà G; Cantoni C; Supino D; Piccio L; Duga S; Asselta R
Hum Mol Genet; 2019 May; 28(9):1414-1428. PubMed ID: 30566690
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNAs: novel links in respiratory diseases (review).
Liu Y; Zhang R; Ying K
Mol Med Rep; 2015 Jun; 11(6):4025-31. PubMed ID: 25647639
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNAs associated with phenotypic severity in multiple sclerosis.
Gupta M; Martens K; Metz LM; de Koning AJ; Pfeffer G
Mult Scler Relat Disord; 2019 Nov; 36():101407. PubMed ID: 31563073
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.
Wang J; Ye C; Xiong H; Shen Y; Lu Y; Zhou J; Wang L
Oncotarget; 2017 Jan; 8(3):5508-5522. PubMed ID: 27732939
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of long noncoding RNAs in autoimmune diseases.
Wu GC; Pan HF; Leng RX; Wang DG; Li XP; Li XM; Ye DQ
Autoimmun Rev; 2015 Sep; 14(9):798-805. PubMed ID: 25989481
[TBL] [Abstract][Full Text] [Related]
19. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of long non-coding RNA profile in peripheral blood of multiple sclerosis patients.
Dastmalchi R; Ghafouri-Fard S; Omrani MD; Mazdeh M; Sayad A; Taheri M
Mult Scler Relat Disord; 2018 Oct; 25():219-226. PubMed ID: 30114626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
